Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Bax Antibody (BAX/962), Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP2444200.1MG
Description
Ensure accurate, reproducible results in Western Blot, Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence
Bax Monoclonal specifically detects Bax in Human, Monkey, Mouse (Negative), Rat (Negative) samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
Bax | |
Monoclonal | |
0.2mg/mL | |
Western Blot 0.5 - 1.0 ug/ml, Flow Cytometry 0.5 - 1 ug/million cells in 0.1 ml, Immunohistochemistry-Paraffin 0.5 - 1.0 ug/ml, Immunofluorescence 1 - 2 ug/ml | |
Q07812 | |
Mouse | |
21 kDa | |
0.1 mg | |
Apoptosis, Cancer, Core ESC Like Genes, Stem Cell Markers, Tumor Suppressors | |
581 | |
Human, Monkey, Mouse (Negative), Rat (Negative) | |
Purified |
Western Blot, Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence | |
BAX/962 | |
Unconjugated | |
10mM PBS and 0.05% BSA with 0.05% Sodium Azide | |
apoptosis regulator BAX, BCL2-associated X protein, Bcl2-L-4, BCL2L4bcl2-L-4, Bcl-2-like protein 4 | |
Recombinant full-length human BAX protein. | |
Protein A or G purified | |
RUO | |
Primary | |
Recognizes a protein of 21kDa, identified as the Bax protein. This MAb is highly specific to Bax and shows no cross-reaction with Bcl-2 or Bcl-X protein. Bcl-2 blocks cell death following a variety of stimuli. Bax has extensive amino acid homology with Bcl-2 and it homodimerizes and forms heterodimers with Bcl-2. Overexpression of Bax accelerates apoptotic death induced by cytokine deprivation in an IL-3 dependent cell line, and Bax also counters the death repressor activity of Bcl-2. | |
Store at 4C. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction